KLA Corporation enters its July 28 print with a notable short interest build, persistent options defensiveness, and a stock down 14% over the past month — all arriving simultaneously ahead of a report that will test whether process control demand can justify its premium.
The short interest story is striking. Short positions now amount to 25.3% of the free float — up 178% over the past month — driven by a step-change in early July when shorts pulled back from roughly 38 million shares to around 32 million, and held there. That is a large number by any standard, yet the borrow market tells a calmer story. Cost to borrow is a negligible 0.51%, and availability remains extremely loose — well above 1,000% of outstanding short interest, meaning the lending pool is nowhere near stressed. There is no squeeze pressure here. The short build looks like a deliberate positioning choice rather than a forced technical trade, and the low borrowing cost suggests new shorts can still enter cheaply.
The options market has taken a separately defensive turn. The put/call ratio hit 1.62 on July 24 — roughly 1.8 standard deviations above its 20-day average of 1.42. That is below the z-score of 3.23 flagged in the July 21 article, meaning the defensive posture has eased slightly but remains elevated. The stock's 3.75% single-day drop on July 24 added to a week that was already down 1%. For holders keeping their positions into earnings, the options hedging pattern is consistent with wanting downside protection rather than outright bearish conviction.
The analyst camp has fractured in a way that makes the debate unusually legible. Bulls — led by Morgan Stanley at $274, Oppenheimer at $260, and TD Cowen, Stifel and Needham all near $270 — point to KLA's dominant position in process control, the intensification of inspection requirements at leading-edge nodes, and a recovering foundry/logic cycle with TSMC as a key customer. Bears, typified by UBS's Timothy Arcuri sitting neutral at $240 (a target he raised then quickly cut within five days), emphasise the risk of capex restraint at Intel, potential export control tightening, and a premium valuation — the stock trades at roughly 36x trailing earnings and 30x EV/EBITDA — that leaves limited room for disappointment. The consensus mean target of $234 is actually below the current price of $210, so the Street's central case still implies some upside, but the distribution of views is wide. Notably, the 30-day EPS momentum factor ranks in the bottom 4th percentile, signalling that forward estimates have been revised down sharply — a meaningful shift heading into a print.
Among peers, the sector moved sharply lower on July 24: AMAT fell 4.7%, LRCX dropped 4.6%, ONTO declined 6.4%, and UCTT shed 7.8%. KLAC fell 3.75% on the same session — less than most of its closest peers — which suggests either relative resilience or simply that a heavier short base is already absorbing some of the selling. The last two earnings prints both produced an initial dip of roughly 3%, with the five-day follow-through flat to slightly positive, so the market has a recent habit of fading the first reaction and then stabilising.
Tomorrow's print is ultimately a test of whether KLA's process control intensity thesis — the idea that chipmakers need more inspection per wafer as nodes shrink — can survive a period of capex caution and deliver guidance strong enough to close the gap between analyst optimism and the stock's sharp pullback.
See the live data behind this article on ORTEX.
Open KLAC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
